Roche Seeks Speedy EU Review For Second Bispecific Antibody

 
• By Neena Brizmohun

The European Medicines Agency was this week deciding whether to grant accelerated assessment for glofitamab.

Calendar
An accelerated assessment can cut months off the drug review time • Source: Alamy

More from Europe

More from Geography